We uncover that DNMT3A, a very important target of E2F complex, is markedly downregulated by MEG3. Given the crucial role of DNMT3A in AML, it is most probably that MEG3 inhibits tumor growth through RB-DNMT3A pathway. Here, RB1 is linked to acute myeloid leukemia.